TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2274802

Group type: EXPERIMENTAL
Intervention: Formal diabetes education programme
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Initial diabetes control and psychosocial factors
Number of subjects: 309
Study: 106963

Group type: EXPERIMENTAL
Intervention: Oral nonabsorbable antibiotics plus isolation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral antibiotics alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 31761149

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention using wearable devices (Fitbit activity tracker, Beddit sleep tracker, Moves app, Careportal home monitoring system) over 210 days
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 70
Study: 31151076

Group type: EXPERIMENTAL
Intervention: Topical human platelet lysate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Topical Clobetasol Propionate
Number of subjects: 30
Study: 28093041

Group type: EXPERIMENTAL
Intervention: Global (single medium)
Number of subjects: 31

Group type: COMPARATOR
Intervention: ISM1/BlastAssist (sequential media)
Number of subjects: 31
Study: 25557208

Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy
Number of subjects: 304

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Subtotal abdominal hysterectomy (after multiple imputation)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (after multiple imputation)
Number of subjects: 304
Study: 23538208

Group type: EXPERIMENTAL
Intervention: RNS(®) System, NeuroPace, Inc. (investigational responsive neurostimulation device)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Depth electrodes
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: Subdural electrodes
Number of subjects: 191
Study: 22018220

Group type: EXPERIMENTAL
Intervention: Iloprost in saline solution for three weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Saline solution only (control group)
Number of subjects: 52
Study: 19583077

Group type: EXPERIMENTAL
Intervention: Manual injection of 0.3 ml/kg lidocaine 0.5%
Number of subjects: 14

Group type: COMPARATOR
Intervention: Automatic pump injection of 0.3 ml/kg lidocaine 0.5%
Number of subjects: 14
Study: 16754920

Group type: EXPERIMENTAL
Intervention: 125 mL of coffee (200 mg of caffeine)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 30-minute nap
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (decaffeinated coffee containing 15 mg of caffeine)
Number of subjects: 12
Study: 14707022

Group type: EXPERIMENTAL
Intervention: Physiological pacemakers
Number of subjects: 1474

Group type: COMPARATOR
Intervention: Ventricular pacemakers
Number of subjects: 1474
Study: 11722052

Group type: EXPERIMENTAL
Intervention: Warm cardiopulmonary bypass (CPB) at 35.5 to 36.5 degrees C
Number of subjects: 300

Group type: COMPARATOR
Intervention: Cold cardiopulmonary bypass (CPB) at 28 degrees C to 30 degrees C
Number of subjects: 300
Study: 9142583

Group type: COMPARATOR
Intervention: Constant light sedation (CLS) over 50 h aiming for a Ramsay score of 2‐3
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Additional night sedation (ANS) with propofol between 2200 h and 0600 h, aiming for a sedation score of 4‐5
Number of subjects: 30

Group type: COMPARATOR
Intervention: Constant light sedation (CLS)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Additional night sedation (ANS)
Number of subjects: 30
Study: 8154631

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 2964080

Group type: EXPERIMENTAL
Intervention: Carbohydrate meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fat meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Protein meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Distilled water (400 ml at room temperature)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Distilled water (400 ml at 4 degrees C)
Number of subjects: 12
Study: 29360932

Group type: EXPERIMENTAL
Intervention: palbociclib plus letrozole
Number of subjects: 666

Group type: COMPARATOR
Intervention: letrozole alone
Number of subjects: 666
Study: 28656452

Group type: EXPERIMENTAL
Intervention: Medication Adherence Rating Scale (MARS)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: First-generation antipsychotic use
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Higher illness severity (MCSI score)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Lower 'acceptance of illness' (MCAS score)
Number of subjects: 218
Study: 26206451

Group type: EXPERIMENTAL
Intervention: Sacrospinous hysteropexy
Number of subjects: 208

Group type: COMPARATOR
Intervention: Vaginal hysterectomy with suspension of the uterosacral ligaments
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Overall anatomical recurrences, functional outcome, quality of life, complications, hospital stay, measures on postoperative recovery, and sexual functioning
Number of subjects: 208
Study: 23782410

Group type: EXPERIMENTAL
Intervention: Vapotherm 2000i at 7 L/min
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fisher & Paykel HHHFNC at 7 L/min
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Vapotherm 2000i at 8 L/min
Number of subjects: 9

Group type: COMPARATOR
Intervention: Fisher & Paykel HHHFNC at 8 L/min
Number of subjects: 9
Study: 20101009

Group type: EXPERIMENTAL
Intervention: Intensive medical intervention (IMI)
Number of subjects: 597

Group type: COMPARATOR
Intervention: Usual care condition (UCC)
Number of subjects: 597
Study: 17935639

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 59
Study: 16859516

Group type: EXPERIMENTAL
Intervention: Operant Behavioural Treatment (OBT)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Treatment (CBT)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Attention-Placebo (AP)
Number of subjects: 125
Study: 14634878

Group type: EXPERIMENTAL
Intervention: Stereotactic aspiration and fibrinolysis with 3 mg rTPA
Number of subjects: 121

Group type: COMPARATOR
Intervention: Conservative treatment according to best medical treatment
Number of subjects: 121
Study: 11013189

Group type: EXPERIMENTAL
Intervention: Silicone IOL
Number of subjects: 200

Group type: COMPARATOR
Intervention: Acrylic IOL
Number of subjects: 200
Study: 8779363

Group type: EXPERIMENTAL
Intervention: Oral benzocaine 20 mg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Lignocaine 100 mg sprayed onto vocal cords
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Nebulised lignocaine 4 ml (4%)
Number of subjects: 23
Study: 1417481

Group type: EXPERIMENTAL
Intervention: Intra‐arterial doxorubicin hydrochloride, limb salvage surgery, and radiation (group A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Cisplatin, isolated limb perfusion, limb salvage surgery, and radiation (group B)
Number of subjects: 38
Study: 6437150

Group type: EXPERIMENTAL
Intervention: Minimal Intervention 1 (MI1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Shortened, less intensive 6-week behavioral weight loss program (three variations)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimal Intervention 2 (MI2)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Full-length behavioral program (two variations)
Number of subjects: 0
Study: 30536746

Group type: EXPERIMENTAL
Intervention: Ipragliflozin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (no additional treatment)
Number of subjects: 49
Study: 30007574

Group type: EXPERIMENTAL
Intervention: GSM 900MHz RF-EMFs emitted from a mobile phone stimulator for 4 hours, SAR 2.287W/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (non-exposed to RF-EMFs)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Comparison of nickel levels between exposed and non-exposed groups
Number of subjects: 20
Study: 26787597

Group type: EXPERIMENTAL
Intervention: Doppler-guided haemorrhoidal artery ligation with mucopexy (Group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Suture mucopexy alone (Group B)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 40
Study: 25517773

Group type: EXPERIMENTAL
Intervention: Denture adhesive (DA) used during the first 15 days
Number of subjects: 50

Group type: COMPARATOR
Intervention: No denture adhesive (DA) used during the first 15 days
Number of subjects: 50
Study: 22042588

Group type: EXPERIMENTAL
Intervention: Transparent soft short hood
Number of subjects: 112
Study: 19720939

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 270
Study: 17805074

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Previous stress fractures
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Lower whole-body bone mineral content
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Younger chronologic age
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Lower dietary calcium intake
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Younger age at menarche
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: History of irregular menstrual periods
Number of subjects: 127
Study: 15205062

Group type: EXPERIMENTAL
Intervention: Menopausal Sexual Interest Questionnaire (MSIQ)
Number of subjects: 0
Study: 11239030

Group type: EXPERIMENTAL
Intervention: Loop diuretics (torasemide or frusemide), 3 mg/kg body weight i.v. every 6 h
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control group (healthy adults)
Number of subjects: 7
Study: 9519355

Group type: EXPERIMENTAL
Intervention: Maximal androgen blockade (goserelin acetate 3.6 mg s.c. once every 4 weeks + flutamide 250 mg 3 x daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bilateral orchiectomy
Number of subjects: 0
Study: 7988809

Group type: EXPERIMENTAL
Intervention: Contact with a medical specialty prior to entering medical school
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Goal of entering family practice
Number of subjects: 161
Study: 3143576

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (1 g for seven days)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Doxycycline (100 mg)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Doxycycline (200 mg)
Number of subjects: 205
Study: 31526792

Group type: EXPERIMENTAL
Intervention: Infertile women
Number of subjects: 75784

Group type: EXPERIMENTAL
Intervention: Infertile women at low risk of mortality
Number of subjects: 75784

Group type: EXPERIMENTAL
Intervention: Infertile women at low risk of cancer mortality
Number of subjects: 75784

Group type: EXPERIMENTAL
Intervention: Infertile women at low risk of breast cancer death
Number of subjects: 75784
Study: 30526560

Group type: EXPERIMENTAL
Intervention: Counselling and a paper based calendar
Number of subjects: 3360

Group type: EXPERIMENTAL
Intervention: Counselling and a cell phone based SMS alert system
Number of subjects: 3360

Group type: EXPERIMENTAL
Intervention: Counselling and smart-phone application
Number of subjects: 3360

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 3360
Study: 27851679

Group type: EXPERIMENTAL
Intervention: Telephone follow-up (TFU) 4 and 14 days after discharge in addition to conventional treatment
Number of subjects: 117

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 117
Study: 24862944

Group type: EXPERIMENTAL
Intervention: SPARKLE classification system
Number of subjects: 275

Group type: COMPARATOR
Intervention: CCS classification system
Number of subjects: 275

Group type: COMPARATOR
Intervention: TOAST classification system
Number of subjects: 275
Study: 22428572

Group type: EXPERIMENTAL
Intervention: All-purpose nipple ointment (APNO)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Lanolin (control)
Number of subjects: 151
Study: 20382075

Group type: EXPERIMENTAL
Intervention: Accelerated regimen of six fractions of radiotherapy per week (n=458)
Number of subjects: 908

Group type: COMPARATOR
Intervention: Conventional regimen of five fractions of radiotherapy per week (n=450)
Number of subjects: 908
Study: 19120717

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM) 20 mg/d, up-titrated to 40 mg/d, then OM/HCTZ 40/12.5 mg/d, and OM/HCTZ 40/25 mg/d
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil (OM)
Number of subjects: 276
Study: 16373084

Group type: EXPERIMENTAL
Intervention: TACO (600-1200 mg DSM)
Number of subjects: 74

Group type: COMPARATOR
Intervention: TACP
Number of subjects: 74
Study: 14599408

Group type: EXPERIMENTAL
Intervention: Saquinavir (SQV)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Indinavir (IDV)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Ritonavir (RTV)
Number of subjects: 137

Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 137
Study: 10936148

Group type: EXPERIMENTAL
Intervention: Lidocaine inhalation (5 mg/kg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Salbutamol inhalation (1.5 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combined lidocaine and salbutamol inhalation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 8733444

Group type: EXPERIMENTAL
Intervention: True ultrasound (0.5 w/cm2, 3 MHz, pulsed 1:4) for eight minutes
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham ultrasound (only the timer activated)
Number of subjects: 19
Study: 1431007

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3904806

Group type: EXPERIMENTAL
Intervention: Short contact therapy with 1%, 2%, and 3% dithranol (30 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Overnight therapy with 1%, 2%, and 3% dithranol
Number of subjects: 30
Study: 30668322

Group type: EXPERIMENTAL
Intervention: Artemisia afra
Number of subjects: 957

Group type: EXPERIMENTAL
Intervention: Artemisia annua
Number of subjects: 957

Group type: COMPARATOR
Intervention: artesunate-amodiaquine (ASAQ)
Number of subjects: 957
Study: 29407494

Group type: EXPERIMENTAL
Intervention: Clear Aligners (CLA)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Self‐Ligated Brackets (SLB)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional Elastomeric Ligated Brackets (ELB)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Self‐Ligated Brackets (SLB) vs Conventional Elastomeric Ligated Brackets (ELB)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Clear Aligners (CLA) vs Conventional Elastomeric Ligated Brackets (ELB)
Number of subjects: 71
Study: 26800106

Group type: EXPERIMENTAL
Intervention: Alitretinoin 30 mg once daily
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 24336915

Group type: EXPERIMENTAL
Intervention: Topical ketorolac tromethamine, 0.45% (Acuvail), 4 times daily for 3 days before surgery
Number of subjects: 20
Study: 22534404

Group type: EXPERIMENTAL
Intervention: Forced left condition during the follicular phase
Number of subjects: 30

Group type: COMPARATOR
Intervention: Menstrual phase
Number of subjects: 30

Group type: COMPARATOR
Intervention: Luteal phase
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Follicular phase
Number of subjects: 30
Study: 20117443

Group type: EXPERIMENTAL
Intervention: Freestyle bioprosthesis
Number of subjects: 166

Group type: COMPARATOR
Intervention: Homograft
Number of subjects: 166
Study: 18842192

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 2717

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 2717

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg
Number of subjects: 2717

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 2717
Study: 16365072

Group type: EXPERIMENTAL
Intervention: Branched-chain amino acids (BCAA) supplementation at 7 graded intakes
Number of subjects: 6
Study: 14551359

Group type: COMPARATOR
Intervention: Enalapril (normotensive group)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Enalapril (hypertensive group)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo (normotensive group)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Atenolol (hypertensive group)
Number of subjects: 89
Study: 10754614

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron
Number of subjects: 2061

Group type: EXPERIMENTAL
Intervention: 0.625 mg droperidol
Number of subjects: 2061

Group type: EXPERIMENTAL
Intervention: 1.25 mg droperidol
Number of subjects: 2061

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2061

Group type: EXPERIMENTAL
Intervention: Prophylactic antiemetic therapy (any active treatment)
Number of subjects: 2061
Study: 8726201

Group type: EXPERIMENTAL
Intervention: Andrews-type table
Number of subjects: 101

Group type: COMPARATOR
Intervention: four-poster-type frame
Number of subjects: 101
Study: 1425820

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg/day)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg/day) alone or in combination with tocopherol
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 800
Study: 3904132

Group type: EXPERIMENTAL
Intervention: Continuous administration of Estracyt
Number of subjects: 95

Group type: COMPARATOR
Intervention: Intermittent administration of Estracyt
Number of subjects: 95
Study: 31446646

Group type: EXPERIMENTAL
Intervention: TNBG-5602
Number of subjects: 0
Study: 28982833

Group type: EXPERIMENTAL
Intervention: Stepwise intervention including customised text message invitation, automated phone call invitation, secretary phone call, family health professional phone call and face-to-face appointment.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stepwise intervention (text messages, phone calls, appointments)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (written letter)
Number of subjects: 0
Study: 26296954

Group type: EXPERIMENTAL
Intervention: Guadecitabine 60 mg/m(2) daily × 5
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Guadecitabine 90 mg/m(2) daily × 5
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Guadecitabine (various doses)
Number of subjects: 93
Study: 23365035

Group type: EXPERIMENTAL
Intervention: WOMAC function items assessment pre-operatively and at 3, 6, 12, and 24 months follow-up
Number of subjects: 1198
Study: 21555686

Group type: EXPERIMENTAL
Intervention: Axitinib plus docetaxel (docetaxel 80 mg/m2 once every 3 weeks plus axitinib 5 mg twice per day)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo plus docetaxel (docetaxel 80 mg/m2 once every 3 weeks plus placebo)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Axitinib plus docetaxel
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo plus docetaxel
Number of subjects: 168
Study: 18057309

Group type: EXPERIMENTAL
Intervention: Serum beta(2)-microglobulin levels
Number of subjects: 1813

Group type: EXPERIMENTAL
Intervention: Cumulative mean Kt/V of beta(2)-microglobulin
Number of subjects: 1813

Group type: COMPARATOR
Intervention: High-flux dialysis
Number of subjects: 1813
Study: 16931508

Group type: EXPERIMENTAL
Intervention: Cabergoline (2 mg single evening dose)
Number of subjects: 43
Study: 15252155

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 13
Study: 10833188

Group type: EXPERIMENTAL
Intervention: Babyhaler with mask
Number of subjects: 40

Group type: COMPARATOR
Intervention: Babyhaler with mouthpiece
Number of subjects: 40

Group type: COMPARATOR
Intervention: Aerochamber with mask
Number of subjects: 40

Group type: COMPARATOR
Intervention: Babyhaler
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 500 ml bottle
Number of subjects: 40
Study: 9061387

Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol (100 micrograms every 3 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral misoprostol (100 micrograms every 3 hours)
Number of subjects: 40
Study: 8464662

Group type: EXPERIMENTAL
Intervention: C/B ADTP booster
Number of subjects: 139
Study: 4032272

Group type: EXPERIMENTAL
Intervention: 4 X 100‐mg chewable tablets chewed before swallowing (CHEW)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 2 X 200‐mg conventional tablets (CT)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 4 X 100‐mg chewable tablets swallowed whole (SW)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 400 mg b.i.d. (projected steady-state)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 200 mg b.i.d. (steady state)
Number of subjects: 6
Study: 31401661

Group type: EXPERIMENTAL
Intervention: Machine learning models using QCT features
Number of subjects: 80
Study: 29739423

Group type: EXPERIMENTAL
Intervention: iSupport, an online self-help training and support program with a maximum of 23 lessons covering various topics related to dementia.
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: iSupport, an online self-help training and support program.
Number of subjects: 208

Group type: COMPARATOR
Intervention: Education-only e-book (comparison group).
Number of subjects: 208
Study: 26721546

Group type: EXPERIMENTAL
Intervention: IB-CBSM
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 58
Study: 23845064

Group type: EXPERIMENTAL
Intervention: Family CBT with a five-session program of BPAM (n=109)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Family CBT-only (n=100)
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: BPAM
Number of subjects: 209

Group type: EXPERIMENTAL
Intervention: Children with nonanxious parents
Number of subjects: 209
Study: 22525310

Group type: EXPERIMENTAL
Intervention: Autologous incubated macrophages
Number of subjects: 43

Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 43
Study: 20204340

Group type: EXPERIMENTAL
Intervention: Percutaneous nephrolithotomy (PNL)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open surgery nephrolithotomy
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PNL
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 40
Study: 17588301

Group type: EXPERIMENTAL
Intervention: Prolonged-release nicotinic acid (Niaspan) at a maximum dose of 2000 mg/day
Number of subjects: 1053

Group type: EXPERIMENTAL
Intervention: Prolonged-release nicotinic acid (Niaspan)
Number of subjects: 1053